{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,9,18]],"date-time":"2023-09-18T05:00:41Z","timestamp":1695013241458},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2014,12,10]],"date-time":"2014-12-10T00:00:00Z","timestamp":1418169600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Clin Immunol"],"published-print":{"date-parts":[[2015,1]]},"DOI":"10.1007\/s10875-014-0117-1","type":"journal-article","created":{"date-parts":[[2014,12,9]],"date-time":"2014-12-09T07:32:59Z","timestamp":1418110379000},"page":"26-31","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Severe XLP Phenotype Caused by a Novel Intronic Mutation in the SH2D1A Gene"],"prefix":"10.1007","volume":"35","author":[{"given":"B.","family":"T\u00f3th","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Solt\u00e9sz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Gyimesi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Csorba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u00c1.","family":"Veres","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u00c1.","family":"L\u00e1nyi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Kov\u00e1cs","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Mar\u00f3di","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Erd\u0151s","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,12,10]]},"reference":[{"key":"117_CR1","doi-asserted-by":"crossref","first-page":"3398","DOI":"10.1182\/blood-2010-03-275909","volume":"116","author":"AH Filipovich","year":"2010","unstructured":"Filipovich AH, Zhang K, Snow AL, Marsh RA. X-linked lymphoproliferative syndromes: brothers or distant cousins? Blood. 2010;116:3398\u2013408.","journal-title":"Blood"},{"key":"117_CR2","doi-asserted-by":"crossref","first-page":"4383","DOI":"10.1182\/blood-2004-08-3269","volume":"105","author":"L Dupre","year":"2005","unstructured":"Dupre L, Andolfi G, Tangye SG, Clementi R, Locatelli F, Arico M, et al. SAP controls the cytolytic activity of CD8 T cells against EBV-infected cells. Blood. 2005;105:4383\u20139.","journal-title":"Blood"},{"key":"117_CR3","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1016\/S0140-6736(75)92004-8","volume":"7913","author":"DT Purtilo","year":"1975","unstructured":"Purtilo DT, Cassel CK, Yang JP, Harper R. X-linked recessive progressive combined variable immunodeficiency (Duncan\u2019s disease). Lancet. 1975;7913:935\u201340.","journal-title":"Lancet"},{"key":"117_CR4","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1203\/00006450-199510000-00001","volume":"38","author":"TA Seemayer","year":"1995","unstructured":"Seemayer TA, Gross TG, Egeler RM, Pirruccello SJ, Davis JR, Kelly CM, et al. X-linked lymphoproliferative disease: twenty-five years after the discovery. Pediatr Res. 1995;38:471\u20138.","journal-title":"Pediatr Res"},{"key":"117_CR5","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1080\/10428190290026240","volume":"43","author":"J S\u00fcmegi","year":"2002","unstructured":"S\u00fcmegi J, Seemayer TA, Huang D, Davis JR, Morra M, Gross TG, et al. A spectrum of mutations in SH2D1A that causes X-linked lymphoproliferative disease and other Epstein-Barr virus-associated illnesses. Leuk Lymphoma. 2002;43:1189\u2013201.","journal-title":"Leuk Lymphoma"},{"key":"117_CR6","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1172\/JCI200523139","volume":"115","author":"CS Ma","year":"2005","unstructured":"Ma CS, Hare NJ, Nichols KE, Dupr\u00e9 L, Andolfi G, Roncarolo MG, et al. Impaired humoral immunity in X-linked lymphoproliferative disease is associated with defective IL-10 production by CD4+ T cells. J Clin Invest. 2005;115:1049\u201359.","journal-title":"J Clin Invest"},{"key":"117_CR7","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1084\/jem.192.3.337","volume":"192","author":"S Parolini","year":"2000","unstructured":"Parolini S, Bottino C, Falco M, Augugliaro R, Giliani S, Franceschini R, et al. X-linked lymphoproliferative disease. 2B4 molecules displaying inhibitory rather than activating function are responsible for the inability of natural killer cells to kill Epstein-Barr virus-infected cells. J Exp Med. 2000;192:337\u201346.","journal-title":"J Exp Med"},{"key":"117_CR8","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.4049\/jimmunol.176.3.1506","volume":"176","author":"AK Cuss","year":"2006","unstructured":"Cuss AK, Avery DT, Cannons JL, Yu LJ, Nichols KE, Shaw PJ, et al. Expansion of functionally immature transitional B cells is associated with human-immunodeficient states characterized by impaired humoral immunity. J Immunol. 2006;176:1506\u201316.","journal-title":"J Immunol"},{"key":"117_CR9","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1182\/blood-2007-10-116269","volume":"112","author":"S Chaganti","year":"2008","unstructured":"Chaganti S, Ma CS, Bell AI, Croom-Carter D, Hislop AD, Tangye SG, et al. Epstein-Barr virus persistence in the absence of conventional memory B cells: IgM\u2009+\u2009IgD\u2009+\u2009CD27+ B cells harbor the virus in X-linked lymphoproliferative disease patients. Blood. 2008;112:672\u20139.","journal-title":"Blood"},{"key":"117_CR10","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.clim.2012.11.007","volume":"146","author":"M Recher","year":"2012","unstructured":"Recher M, Fried AJ, Massaad MJ, Kim HY, Rizzini M, Frugoni F, et al. Intronic SH2D1A mutation with impaired SAP expression and agammaglobulinemia. Clin Immunol. 2012;146:84\u20139.","journal-title":"Clin Immunol"},{"key":"117_CR11","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1034\/j.1600-065X.2003.00023.x","volume":"192","author":"S Latour","year":"2003","unstructured":"Latour S, Veillette A. Molecular and immunological basis of X-linked lymphoproliferative disease. Immunol Rev. 2003;192:212\u201324.","journal-title":"Immunol Rev"},{"key":"117_CR12","doi-asserted-by":"crossref","first-page":"13765","DOI":"10.1073\/pnas.95.23.13765","volume":"95","author":"KE Nichols","year":"1998","unstructured":"Nichols KE, Harkin DP, Levitz S, Krainer M, Kolquist KA, Genovese C, et al. Inactivating mutations in an SH2 domain-encoding gene in X-linked lymphoproliferative syndrome. Proc Natl Acad Sci U S A. 1998;95:13765\u201370.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"117_CR13","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1182\/blood-2010-07-298372","volume":"117","author":"J Pachlopnik Schmid","year":"2011","unstructured":"Pachlopnik Schmid J, Canioni D, Moshous D, Touzot F, Mahlaoui N, Hauck F, et al. Clinical similarities and differences of patients with X-linked lymphoproliferative syndrome type 1 (XLP-1\/SAP deficiency) versus type 2 (XLP-2\/XIAP deficiency). Blood. 2011;117:1522\u20139.","journal-title":"Blood"},{"key":"117_CR14","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1182\/blood.V98.4.1268","volume":"98","author":"R Sumazaki","year":"2001","unstructured":"Sumazaki R, Kanegane H, Osaki M, Fukushima T, Tsuchida M, Matsukura H, et al. SH2D1A mutations in Japanese males with severe Epstein-Barr virus\u2013associated illnesses. Blood. 2001;98:1268\u201370.","journal-title":"Blood"},{"key":"117_CR15","doi-asserted-by":"crossref","first-page":"2407","DOI":"10.1093\/hmg\/8.13.2407","volume":"8","author":"O Brandau","year":"1999","unstructured":"Brandau O, Schuster V, Weiss M, Hellebrand H, Fink FM, Kreczy A, et al. Epstein-Barr virus-negative boys with non-Hodgkin lymphoma are mutated in the SH2D1A gene, as are patients with X-linked lymphoproliferative disease (XLP). Hum Mol Genet. 1999;8:2407\u201313.","journal-title":"Hum Mol Genet"},{"key":"117_CR16","first-page":"3118","volume":"96","author":"J S\u00fcmegi","year":"2000","unstructured":"S\u00fcmegi J, Huang D, L\u00e1nyi A, Davis JD, Seemayer TA, Maeda A, et al. Correlation of mutations of the SH2D1A gene and epstein-barr virus infection with clinical phenotype and outcome in X-linked lymphoproliferative disease. Blood. 2000;96:3118\u201325.","journal-title":"Blood"},{"key":"117_CR17","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1038\/26683","volume":"395","author":"J Sayos","year":"1998","unstructured":"Sayos J, Wu C, Morra M, Wang N, Zhang X, Allen D, et al. The X-linked lymphoproliferative-disease gene product SAP regulates signals induced through the co-receptor SLAM. Nat. 1998;395:462\u20139.","journal-title":"Nat"},{"key":"117_CR18","doi-asserted-by":"crossref","first-page":"3066","DOI":"10.1182\/blood-2004-09-3651","volume":"105","author":"Y Tabata","year":"2005","unstructured":"Tabata Y, Villanueva J, Lee SM, Zhang K, Kanegane H, Miyawaki T, et al. Rapid detection of intracellular SH2D1A protein in cytotoxic lymphocytes from patients with X-linked lymphoproliferative disease and their family members. Blood. 2005;105:3066\u201371.","journal-title":"Blood"},{"key":"117_CR19","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1002\/pbc.21216","volume":"50","author":"M Debeljak","year":"2008","unstructured":"Debeljak M, Podkrajsek KT, Aplenc R, Jazbec J. X-linked lymphoproliferative disease with a novel SH2D1A gene mutation. Pediatr Blood Cancer. 2008;50:187.","journal-title":"Pediatr Blood Cancer"},{"key":"117_CR20","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1038\/2424","volume":"20","author":"AJ Coffey","year":"1998","unstructured":"Coffey AJ, Brooksbank RA, Brandau O, Oohashi T, Howell GR, Bye JM, et al. Host response to EBV infection in X-linked lymphoproliferative disease results from mutations in an SH2-domain encoding gene. Nat Genet. 1998;20:129\u201335.","journal-title":"Nat Genet"},{"key":"117_CR21","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1007\/s004390051137","volume":"105","author":"L Yin","year":"1999","unstructured":"Yin L, Ferrand V, Lavou\u00e9 MF, Hayoz D, Philippe N, Souillet G, et al. SH2D1A mutation analysis for diagnosis of XLP in typical and atypical patients. Hum Genet. 1999;105:501\u20135.","journal-title":"Hum Genet"},{"key":"117_CR22","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1002\/humu.9339","volume":"25","author":"M Erd\u0151s","year":"2005","unstructured":"Erd\u0151s M, Uzv\u00f6lgyi E, Nemes Z, T\u00f6r\u00f6k O, R\u00e1k\u00f3czi E, Went-S\u00fcmegi N, et al. Characterization of a new disease-causing mutation of SH2D1A in a family with X-linked lymphoproliferative disease. Hum Mutat. 2005;25:506.","journal-title":"Hum Mutat"},{"key":"117_CR23","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1002\/1097-0215(20001101)88:3<439::AID-IJC17>3.0.CO;2-#","volume":"88","author":"N Nagy","year":"2000","unstructured":"Nagy N, Cerboni C, Mattsson K, Maeda A, Gogolak P, S\u00fcmegi J, et al. SH2D1A and SLAM protein expression in human lymphocytes and derived cell lines. Int J Cancer. 2000;88:439\u201347.","journal-title":"Int J Cancer"},{"key":"117_CR24","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1136\/jmedgenet-2013-101570","volume":"50","author":"B Solt\u00e9sz","year":"2013","unstructured":"Solt\u00e9sz B, T\u00f3th B, Shabashova N, Bondarenko A, Okada S, Cypowyj S, et al. New and recurrent gain-of-function STAT1 mutations in patients with chronic mucocutaneous candidiasis from Eastern and Central Europe. J Med Genet. 2013;50:567\u201378.","journal-title":"J Med Genet"}],"container-title":["Journal of Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10875-014-0117-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10875-014-0117-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10875-014-0117-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,31]],"date-time":"2019-05-31T04:14:59Z","timestamp":1559276099000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10875-014-0117-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,12,10]]},"references-count":24,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,1]]}},"alternative-id":["117"],"URL":"https:\/\/doi.org\/10.1007\/s10875-014-0117-1","relation":{},"ISSN":["0271-9142","1573-2592"],"issn-type":[{"value":"0271-9142","type":"print"},{"value":"1573-2592","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,12,10]]}}}